NCT02510768View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 16, 2015

Primary Completion Date

October 3, 2017

Study Completion Date

March 6, 2018

Conditions
Striae Distensae
Interventions
DEVICE

ELAPR002f

Intradermal implant

DEVICE

ELAPR002g

Intradermal implant

DEVICE

Saline

Intradermal implant

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

All Listed Sponsors
lead

Elastagen Pty Ltd

INDUSTRY

NCT02510768 - A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba | Biotech Hunter | Biotech Hunter